Bayer Affirms FY2026 currency-adjusted Adj EPS Guidance of $1.20-$1.35 vs $1.25 Est; Affirms FY2026 currency-adjusted Sales Guidance of $52.109B-$54.451B vs $52.110B Est

Bayer (OTC:BAYRY) affirms FY2026 currency-adjusted Adj EPS guidance from $1.20-$1.35 to $1.20-$1.35 vs $1.25 analyst estimate. Affirms FY2026 currency-adjusted sales outlook from $52.109 billion-$54.451 billion to $52.109 billion-$54.451 billion vs $52.110 billion estimate.